{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:37:03Z","timestamp":1791232623508,"version":"4.1.0"},"reference-count":60,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,6,21]],"date-time":"2021-06-21T00:00:00Z","timestamp":1624233600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>L-Thyroxine (T4) is the principal ligand of the thyroid hormone analogue receptor on the extracellular domain of integrin \u03b1v\u03b23. The integrin is overexpressed and activated in cancer cells, rapidly dividing endothelial cells, and platelets. The biologic result is that T4 at physiological concentration and without conversion to 3,3\u2019,5-triiodo-L-thyronine (T3) may stimulate cancer cell proliferation and cancer-relevant angiogenesis and platelet coagulation. Pro-thrombotic activity of T4 on platelets is postulated to support cancer-linked blood clotting and to contribute to tumor cell metastasis. We examine some of these findings as they may relate to cancers of the thyroid. Differentiated thyroid cancer cells respond to physiological levels of T4 with increased proliferation. Thus, the possibility exists that in patients with differentiated thyroid carcinomas in whom T4 administration and consequent endogenous thyrotropin suppression have failed to arrest the disease, T4 treatment may be stimulating tumor cell proliferation. <jats:italic>In vitro<\/jats:italic> studies have shown that tetraiodothyroacetic acid (tetrac), a derivative of T4, acts <jats:italic>via<\/jats:italic> the integrin to block T4 support of thyroid cancer and other solid tumor cells. Actions of T4 and tetrac or chemically modified tetrac modulate gene expression in thyroid cancer cells. T4 induces radioresistance <jats:italic>via<\/jats:italic> induction of a conformational change in the integrin in various cancer cells, although not yet established in thyroid cancer cells. The thyroid hormone receptor on integrin \u03b1v\u03b23 mediates a number of actions of T4 on differentiated thyroid cancer cells that support the biology of the cancer. Additional studies are required to determine whether T4 acts on thyroid cancer cells.<\/jats:p>","DOI":"10.3389\/fendo.2021.691736","type":"journal-article","created":{"date-parts":[[2021,6,21]],"date-time":"2021-06-21T06:42:52Z","timestamp":1624257772000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":19,"title":["Actions of Thyroid Hormones on Thyroid Cancers"],"prefix":"10.3389","volume":"12","author":[{"given":"Shaker A.","family":"Mousa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleck","family":"Hercbergs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung-Yun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly A.","family":"Keating","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,6,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1210\/en.2005-0102","article-title":"Integrin \u03b1V\u03b23 Contains a Cell Surface Receptor Site for Thyroid Hormone That Is Linked to Activation of Mitogen-Activated Protein Kinase and Induction of Angiogenesis","volume":"146","author":"Bergh","year":"2005","journal-title":"Endocrinology"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2015.205","article-title":"Nongenomic Actions of Thyroid Hormone","volume":"12","author":"Davis","year":"2016","journal-title":"Nat Rev Endocrinol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00038.2019","article-title":"Nongenomic Actions of Thyroid Hormone: The Integrin Component","volume":"101","author":"Davis","year":"2021","journal-title":"Physiol Rev"},{"key":"B4","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nrc2748","article-title":"Integrins in Cancer: Biological Implications and Therapeutic Opportunities","volume":"10","author":"Desgrosellier","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1210\/er.2009-0007","article-title":"Molecular Aspects of Thyroid Hormone Actions","volume":"31","author":"Cheng","year":"2010","journal-title":"Endocr Rev"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1080\/07435800.2018.1456550","article-title":"Activation of Tumor Cell Integrin \u03b1v\u03b23 by Radiation and Reversal of Activation by Chemically Modified Tetraiodothyroacetic Acid (Tetrac)","volume":"43","author":"Leith","year":"2018","journal-title":"Endocr Res"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.4023","article-title":"Thyroid Hormone and Anti-Apoptosis in Tumor Cells","volume":"6","author":"Lin","year":"2015","journal-title":"Oncotarget"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.26434","article-title":"Radioresistance of Cancer Cells, Integrin \u03b1v\u03b23 and Thyroid Hormone","volume":"9","author":"Leith","year":"2018","journal-title":"Oncotarget"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/s10456-014-9418-5","article-title":"Modulation of Angiogenesis by Thyroid Hormone and Hormone Analogues: Implications for Cancer Management","volume":"17","author":"Mousa","year":"2014","journal-title":"Angiogenesis"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1002\/cphy.c150011","article-title":"Thyroid Hormone, Hormone Analogs, and Angiogenesis","volume":"6","author":"Davis","year":"2015","journal-title":"Compr Physiol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00775","article-title":"Tetrac Delayed the Onset of Ocular Melanoma in an Orthotopic Mouse Model","volume":"9","author":"Ashur-Fabian","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.2217\/nnm.12.200","article-title":"Tetraiodothyroacetic Acid-Conjugated PLGA Nanoparticles: A Nanomedicine Approach to Treat Drug-Resistant Breast Cancer","volume":"8","author":"Bharali","year":"2013","journal-title":"Nanomedicine (Lond)"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.00095","article-title":"\u03b1v\u03b23 Integrin Antagonists Enhance Chemotherapy Response in an Orthotopic Pancreatic Cancer Model","volume":"11","author":"Debreli Coskun","year":"2020","journal-title":"Front Pharmacol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/s12672-017-0293-6","article-title":"Nanoparticulate Tetrac Inhibits Growth and Vascularity of Glioblastoma Xenografts","volume":"8","author":"Sudha","year":"2017","journal-title":"Horm Cancer"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2014-0308","article-title":"Medically Induced Euthyroid Hypothyroxinemia may Extend Survival in Compassionate Need Cancer Patients: An Observational Study","volume":"20","author":"Hercbergs","year":"2015","journal-title":"Oncologist"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.25422","article-title":"Hypothyroidism in Patients With Renal Cell Carcinoma: Blessing or Curse","volume":"117","author":"Schmidinger","year":"2011","journal-title":"Cancer"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.20881","article-title":"Thyroid Hormone and Breast Carcinoma. Primary Hypothyroidism is Associated With a Reduced Incidence of Primary Breast Carcinoma","volume":"103","author":"Cristofanilli","year":"2005","journal-title":"Cancer"},{"key":"B18","article-title":"Propylthiouracil-Induced Chemical Hypothyroidism With High-Dose Tamoxifen Prolongs Survival in Recurrent High Grade Glioma: A Phase I\/II Study","volume":"23","author":"Hercbergs","year":"2003","journal-title":"Anticancer Res"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1001\/archotol.132.10.1041","article-title":"Association Between Development of Hypothyroidism and Improved Survival in Patients With Head and Neck Cancer","volume":"132","author":"Nelson","year":"2006","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.steroids.2006.11.014","article-title":"Thyroid Hormone Is a MAPK-Dependent Growth Factor for Thyroid Cancer Cells and Is Anti-Apoptotic","volume":"72","author":"Lin","year":"2007","journal-title":"Steroids"},{"key":"B21","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s12672-014-0204-z","article-title":"Recurrence of Differentiated Thyroid Carcinoma During Full TSH Suppression: Is the Tumor Now Thyroid Hormone Dependent","volume":"6","author":"Davis","year":"2015","journal-title":"Horm Cancer"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2009.0249","article-title":"Tetraiodothyroacetic Acid and Tetraiodothyroacetic Acid Nanoparticle Effectively Inhibit the Growth of Human Follicular Thyroid Cell Carcinoma","volume":"20","author":"Yalcin","year":"2010","journal-title":"Thyroid"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3390\/genes11070755","article-title":"Actions of L-thyroxine (T4) and Tetraiodothyroacetic Acid (Tetrac) on Gene Expression in Thyroid Cancer Cells","volume":"11","author":"Davis","year":"2020","journal-title":"Genes (Basel)"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-1926","article-title":"Tetraiodothyroacetic Acid (Tetrac) and Nanoparticulate Tetrac Arrest Growth of Medullary Carcinoma of the Thyroid","volume":"95","author":"Yalcin","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/sj.emboj.7600616","article-title":"Thyrotropin Receptor Trafficking Relies on the hScrib-\u03b2PIX-GIT1-ARF6 Pathway","volume":"24","author":"Lahuna","year":"2005","journal-title":"EMBO J"},{"key":"B26","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/s41467-017-00357-2","article-title":"Internalized TSH Receptors en Route to the TGN Induce Local Gs-protein Signaling and Gene Transcription","volume":"8","author":"Godbole","year":"2017","journal-title":"Nat Commun"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/s41556-018-0223-z","article-title":"Integrin Trafficking in Cells and Tissues","volume":"21","author":"Moreno-Layseca","year":"2019","journal-title":"Nat Cell Biol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1096\/fj.12-227132","article-title":"Nuclear Monomeric Integrin \u03b1v in Cancer Cells Is a Coactivator Regulated by Thyroid Hormone","volume":"27","author":"Lin","year":"2013","journal-title":"FASEB J"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.1996.271.4.C1256","article-title":"Potentiation by Thyroxine of Interferon-Gamma-Induced Antiviral State Requires PKA and PKC Activities","volume":"271","author":"Lin","year":"1996","journal-title":"Am J Physiol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1055\/s-0030-1265216","article-title":"Involvement of the cyclic-AMP-dependent Protein Kinase A Pathway in Thyroxine Effects on Calcitonin Secretion From TT Cells","volume":"43","author":"Lu","year":"2011","journal-title":"Horm Metab Res"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/341282","article-title":"Integrin and GPCR Crosstalk in the Regulation of ASM Contraction Signaling in Asthma","volume":"2012","author":"Teoh","year":"2012","journal-title":"J Allergy (Cairo)"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1210\/mend.16.5.0820","article-title":"TSH Receptor Interaction With the Extracellular Matrix: Role on Constitutive Activity and Sensitivity to Hormonal Stimulation","volume":"16","author":"Ghinea","year":"2002","journal-title":"Mol Endocrinol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17091484","article-title":"Effect of Thyrotropin on Osteopontin, Integrin \u03b1v\u03b23 and VCAM-1 in the Endothelium Via Activation of Akt","volume":"17","author":"Yan","year":"2016","journal-title":"Int J Mol Sci"},{"key":"B34","doi-asserted-by":"publisher","first-page":"e187754","DOI":"10.1001\/jamanetworkopen.2018.7754","article-title":"Association of Thyrotropin Suppression With Survival Outcomes in Patients With Intermediate- and High-Risk Differentiated Thyroid Cancer","volume":"2","author":"Klubo-Gwiezdzinska","year":"2019","journal-title":"JAMA Netw Open"},{"key":"B35","article-title":"Abstract: Regulation of Cancer Cell Metabolism Via the Thyroid Hormone Analogue Receptor on Integrin \u03b1V\u03b23: Action of P-bi-TAT (tetrac-PEG) at the Receptor","author":"Davis","year":"2018"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines6030089","article-title":"Contributions of Thyroid Hormone to Cancer Metastasis","volume":"6","author":"Mousa","year":"2018","journal-title":"Biomedicines"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1007\/s12672-019-00371-4","article-title":"Platelet ATP, Thyroid Hormone Receptor on Integrin \u03b1v\u03b23 and Cancer Metastasis","volume":"11","author":"Davis","year":"2020","journal-title":"Horm Cancer"},{"key":"B38","doi-asserted-by":"publisher","first-page":"e0130496","DOI":"10.1371\/journal.pone.0130496","article-title":"miR-126-3p Inhibits Thyroid Cancer Cell Growth and Metastasis, and is Associated With Aggressive Thyroid Cancer","volume":"10","author":"Xiong","year":"2015","journal-title":"PloS One"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1172\/JCI60047","article-title":"Mechanisms of Thyroid Hormone Action","volume":"122","author":"Brent","year":"2012","journal-title":"J Clin Invest"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00739","article-title":"Bioactivity of Thyroid Hormone Analogs at Cancer Cells","volume":"9","author":"Davis","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1080\/07435800.2019.1600536","article-title":"Action of Reverse T3 on Cancer Cells","volume":"44","author":"Lin","year":"2019","journal-title":"Endocr Res"},{"key":"B42","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s13000-017-0662-z","article-title":"PD-L1 and PD-1 Expression are Correlated With Distinctive Clinicopathological Features in Papillary Thyroid Carcinoma","volume":"12","author":"Bai","year":"2017","journal-title":"Diagn Pathol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.8698","article-title":"Programmed Death-Ligand 1 Overexpression is a Prognostic Marker for Aggressive Papillary Thyroid Cancer and its Variants","volume":"7","author":"Chowdhury","year":"2016","journal-title":"Oncotarget"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2017.03.031","article-title":"Programmed Death - Ligand 1 Expression Distinguishes Invasive Encapsulated Follicular Variant of Papillary Thyroid Carcinoma From Noninvasive Follicular Thyroid Neoplasm With Papillary-Like Nuclear Features","volume":"18","author":"Fu","year":"2017","journal-title":"EBioMedicine"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.26143","article-title":"In Tumor Cells, Thyroid Hormone Analogues Non-Immunologically Regulate PD-L1 and PD-1 Accumulation That Is Anti-Apoptotic","volume":"9","author":"Lin","year":"2018","journal-title":"Oncotarget"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1080\/15384101.2016.1269044","article-title":"In Vitro Effects of Tetraiodothyroacetic Acid Combined With X-Irradiation on Basal Cell Carcinoma Cells","volume":"16","author":"Leith","year":"2017","journal-title":"Cell Cycle"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.1794","article-title":"Radioiodine Refractoriness Score: A Multivariable Prediction Model for Postoperative Radioiodine-Refractory Differentiated Thyroid Carcinomas","volume":"7","author":"Li","year":"2018","journal-title":"Cancer Med"},{"key":"B48","article-title":"Optimizing Therapy for Radioactive Iodine-Refractory Differentiated Thyroid Cancer: Current State of the Art and Future Directions","volume":"37","author":"Dadu","year":"2012","journal-title":"Minerva Endocrinol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00130","article-title":"Tetrac and NDAT Induce Anti-Proliferation Via Integrin \u03b1v\u03b23 in Colorectal Cancers With Different K-RAS Status","volume":"10","author":"Chin","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1021\/acs.bioconjchem.9b00742","article-title":"Triazole Modified Tetraiodothyroacetic Acid Conjugated to Polyethylene Glycol: High Affinity Thyrointegrin \u03b1v\u03b23 Antagonist With Potent Anticancer Activities in Glioblastoma Multiforme","volume":"30","author":"Rajabi","year":"2019","journal-title":"Bioconjug Chem"},{"key":"B51","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1007\/s12020-018-1607-3","article-title":"Risk Factors for Central Neck Lymph Node Metastases in Follicular Variant vs. Classic Papillary Thyroid Carcinoma","volume":"62","author":"Raffaelli","year":"2018","journal-title":"Endocrine"},{"key":"B52","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.mce.2017.03.015","article-title":"Role of microRNAs in Endocrine Cancer Metastasis","volume":"456","author":"Lima","year":"2017","journal-title":"Mol Cell Endocrinol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"625","DOI":"10.3390\/biom10040625","article-title":"Association of microRNA Expression and BRAF(V600E) Mutation With Recurrence of Thyroid Cancer","volume":"10","author":"Pamedytyte","year":"2020","journal-title":"Biomolecules"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.7150\/jca.13898","article-title":"MicroRNA Expression Profiles in Papillary Thyroid Carcinoma, Benign Thyroid Nodules and Healthy Controls","volume":"7","author":"Yoruker","year":"2016","journal-title":"J Cancer"},{"key":"B55","doi-asserted-by":"publisher","first-page":"e5621","DOI":"10.1097\/md.0000000000005621","article-title":"Anaplastic Thyroid Carcinoma and Foscarnet Use in a Multitarget Treatment Documented by 18F-FDG PET\/CT: A Case Report","volume":"96","author":"Giannetta","year":"2017","journal-title":"Medicine"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.00102","article-title":"Update on Fundamental Mechanisms of Thyroid Cancer","volume":"11","author":"Prete","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-06-4477","article-title":"Epigenetically Controlled Fibroblast Growth Factor Receptor 2 Signaling Imposes on the RAS\/BRAF\/mitogen-Activated Protein Kinase Pathway to Modulate Thyroid Cancer Progression","volume":"67","author":"Kondo","year":"2007","journal-title":"Cancer Res"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01124","article-title":"Interleukins in Thyroid Cancer: From Basic Researches to Applications in Clinical Practice","volume":"11","author":"Xi","year":"2020","journal-title":"Front Immunol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3109\/07435800.2013.778865","article-title":"Molecular Mechanisms of Actions of Formulations of the Thyroid Hormone Analogue, Tetrac, on the Inflammatory Response","volume":"38","author":"Davis","year":"2013","journal-title":"Endocr Res"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1080\/07435800.2020.1767127","article-title":"Coronaviruses and Integrin \u03b1V\u03b23: Does Thyroid Hormone Modify the Relationship","volume":"45","author":"Davis","year":"2020","journal-title":"Endocr Res"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.691736\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,21]],"date-time":"2021-06-21T06:42:57Z","timestamp":1624257777000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.691736\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,21]]},"references-count":60,"alternative-id":["10.3389\/fendo.2021.691736"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2021.691736","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,21]]},"article-number":"691736"}}